Table 3.
Correlation between CD133/ALDH1 phenotypes and clinicopathological characteristics in CRC
| Patients and tumor characteristics | CD133/ALDH1 phenotypes | P | |||
|---|---|---|---|---|---|
| CD133High/ ALDH1High | CD133Low/ALDH1Low | CD133High/ ALDH1Low | CD133Low/ ALDH1High | ||
| Gender Male Female |
13(8.3) 12(9.4) |
17(10.9) 8(6.3) |
125(80.1) 105(82.7) |
1(0.6) 2(1.6) |
0.49 |
| Age ≤60 >60 |
14(9.4) 11(8.2) |
13(8.7) 12(9) |
121(81.2) 109(81.3) |
1(0.7) 2(1.5) |
0.90 |
| Tumor size ≤5 >5 |
14(7.3) 11(12.2) |
16(8.3) 9(10) |
160(82.9) 70(77.8) |
3(1.6) 0(0) |
0.32 |
| Vascular invasion Yes No |
4(12.1) 21(8.4) |
2(6.1) 23(9.2) |
27(81.8) 203(81.2) |
0(0) 3(1.2) |
0.76 |
| Neural invasion Yes No |
0(0) 25(10.5) |
1(2.3) 24(10.1) |
42(95.5) 188(78.6) |
1(2.3) 2(0.8) |
0.03 |
| Lymph node involvement Yes No |
9(9.4) 16(8.6) |
7(7.3) 18(9.6) |
80(83.3) 150(80.2) |
0(0) 3(1.6) |
0.56 |
| Metastasis Yes No |
1(5.6) 24(9.1) |
2(11.1) 23(8.7) |
15(83.3) 215(81.1) |
0(0) 3(1.1) |
0.90 |
| Differentiation Well Moderate & Poor |
11(10.2) 14(8) |
9(8.3) 16(9.1) |
85(78.7) 145(82.9) |
3(2.8) 0(0) |
0.14 |
*The values shown in bold are statistically significant